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Our intestinal microbiota harbors a diverse micro-
bial community, often containing opportunistic
bacteria with virulence potential. However, mutual-
istic host-microbial interactions prevent disease by
opportunistic pathogens through poorly understood
mechanisms. We show that the epithelial inter-
leukin-22 receptor IL-22RA1 protects against lethal
Citrobacter rodentium infection and chemical-
induced colitis by promoting colonization resis-
tance against an intestinal opportunistic bacterium,
Enterococcus faecalis. Susceptibility of Il22ra1/
mice to C. rodentium was associated with preferen-
tial expansion and epithelial translocation of patho-
genic E. faecalis during severe microbial dysbiosis
and was ameloriated with antibiotics active against
E. faecalis. RNA sequencing analyses of primary
colonic organoids showed that IL-22RA1 signaling
promotes intestinal fucosylation via induction of the
fucosyltransferase Fut2. Additionally, administration
of fucosylated oligosaccharides to C. rodentium-
challenged Il22ra1/ mice attenuated infection and
promoted E. faecalis colonization resistance by
restoring the diversity of anaerobic commensal
symbionts. These results support a model whereby
IL-22RA1 enhances host-microbiota mutualism to
limit detrimental overcolonization by opportunistic
pathogens.
INTRODUCTION
The mammalian gastrointestinal tract harbors a dense and
diverse microbial community that is essential for host nutrient
acquisition, immune development, and pathogen defense. In
health, the microbiota consists mainly of obligate anaerobes
and can act as an effective barrier to prevent colonization and
access of pathogenic microbes to host tissues. Colonization504 Cell Host & Microbe 16, 504–516, October 8, 2014 ª2014 The Auresistance to enteric pathogens is thought to involve mutualistic
interactions between the host immune system and the com-
mensal microbiota through mechanisms that remain poorly un-
derstood. Moreover, while many host-commensal associations
are considered symbiotic, the microbiota also contains indige-
nous opportunistic microbes, which can potentially trigger intes-
tinal or systemic pathology particularly during perturbations of
the intestinal ecosystem (Stecher and Hardt, 2008). In most
healthy individuals, however, these opportunistic pathogens
fail to replicate to sufficient levels to colonize the mucosal sur-
face or to invade the host systemic organs, suggesting the
importance of mechanisms to restrict their overcolonization
and virulence expression.
Interleukin-22 (IL-22) is an important cytokine for maintaining
homeostasis at various mucosal barriers, including the gastroin-
testinal tract (Sonnenberg et al., 2011). During infection with en-
teropathogens such as Salmonella Typhimurium andCitrobacter
rodentium, IL-22 is highly upregulated, leading to induction of
multiple antimicrobial and inflammatory factors (Raffatellu et al.,
2008; Zheng et al., 2008). The protective function of IL-22 is
evident by the observations that Il22/ mice are susceptible to
Gram-negative pathogens, includingC. rodentium andKlebsiella
pneumoniae (Aujla et al., 2008; Zheng et al., 2008). In contrast, IL-
22 deficiency is not associated with enhanced susceptibility to
Neisseria gonorrhoea, Listeria monocytogenes, or the patho-
genic protozoan Toxoplasma gondii (Feinen and Russell, 2012;
Graham et al., 2011; Wilson et al., 2010), and IL-22 can even pro-
mote S. Typhimurium colonization (Behnsen et al., 2014). These
findings suggest that the effects of IL-22 on pathogen coloniza-
tion resistance are highly complex and varied depending on the
inflammatory stimuli and the indigenous microbiota.
IL-22 signals through a heterodimeric receptor complex con-
sisting of a ubiquitously expressed IL-10Rb subunit and an
IL-22RA1 subunit, which has a remarkably tissue-specific distri-
bution. IL-22RA1 expression is limited to a few organs (e.g., liver,
kidney) and barrier surfaces such as the skin and gastrointestinal
tract, where it is thought to mediate the effects of IL-22 in main-
taining barrier homeostasis (Wolk et al., 2004; Zheng et al.,
2008). Given the complex antimicrobial function of IL-22, in the
present study we set out to elucidate the impact of IL-22RA1
on the resident microbiota and the maintenance of pathogen
colonization resistance.thors
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Figure 1. IL-22RA1 Limits Systemic Bacterial Dissemination during Intestinal Disease
(A) C. rodentium cfus in systemic organs.
(B) Serum anti-C. rodentium EspA IgG titer.
(C and D) TNF-a and IL-6 cytokines (C) and E. faecalis cfus (D) in systemic organs of infectedWT and Il22ra1/mice. Shown are mean ± SEM in five independent
infections (n = 4–6 each); ***p < 0.0001.
(E and F) Profile of systemic bacterial isolates from (E) WT (n = 10) and Il22ra1/mice infected with C. rodentium (n = 28) and (F) DSS-treated WT and Il22ra1/
mice (n = 8–10). Numbers indicate total number of isolates assigned to a particular bacterial taxon in 3–8 independent experiments. See also Figure S2 and Tables
S1 and S2.
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IL-22RA1 Induces Opportunistic Pathogen ResistanceRESULTS
IL-22RA1 Limits Systemic Bacterial Dissemination
during Intestinal Inflammation
We generated Il22ra1/ mice homozygous for the targeted
Il22ra1tm1a(KOMP)Wtsi allele (Skarnes et al., 2011) and confirmed
that within the gastrointestinal tract, endogenous Il22ra1
expression is restricted to the epithelium (Figures S1A and
S1B, available online). By a global phenotyping approach (White
et al., 2013), we found no obvious systemic or intestinal pathol-
ogy in specific pathogen-free (SPF) Il22ra1/ mice (Figures
S1C–S1E). 16S rRNA gene pyrosequencing revealed no signifi-
cant difference in the diversity and community structure of the
baseline microbiota between wild-type (WT) and Il22ra1/
mice (Figures S1F and S1G). Next, we infected Il22ra1/
mice with pathogens to discern the role of IL-22RA1 in systemic
and intestinal host defenses. IL-22RA1 is not required for pro-
tection against systemic Salmonella Typhimurium, as all
Il22ra1/ mice survived intravenous Salmonella infection and
were able to clear the bacteria in a manner similar to that of
WT mice (Figures S2A–S2C). By contrast, similarly to Il22/
mice (Zheng et al., 2008), Il22ra1/ mice were highly suscepti-
ble to the attaching-effacing enteropathogen C. rodentium (Fig-
ures S2D and S2E).Cell HosWe next examined the impact of IL-22RA1 on mucosal immu-
nity to C. rodentium. Infected Il22ra1/ mice had significantly
higher transcript and protein expression of proinflammatory
Th1-type cytokines (interferon gamma [IFNg], IL-1b, IL-6, tumor
necrosis factor alpha [TNF-a]) and Th17-type cytokines (IL-17a,
IL-17f, IL-21, IL-22) in the cecal tissues and isolated colonic lam-
ina propria (cLP) leukocytes (Figure S3A). This is consistent with
an 3-fold accumulation of IFNg- and IL-17a-producing CD4+
T cells in the cLP of infected Il22ra1/ mice (Figures S3B–
S3D), whereas B cells, Foxp3+ regulatory T cells, neutrophils,
and inflammatory macrophages were at frequencies similar to
that of WT (Figures S3E and S3F). We also detected similar titers
of total andCitrobacter-specific immunoglobulin A (IgA) in the in-
testine of Il22ra1/mice compared to WT mice at day 9 postin-
fection (p.i.) (Figure S3G). Thus, susceptibility of Il22ra1/ mice
to C. rodentium is not associated with an insufficient mucosal
immune response.
Notably, infected Il22ra1/ mice showed a high systemic
burden of C. rodentium, accompanied by elevated serum titers
of Citrobacter-specific IgG (Figures 1A and 1B). Furthermore,
serum levels of the proinflammatory cytokines IL-6 and TNF-a
were significantly increased (Figure 1C), suggesting dissemina-
tion of gut bacteria and systemic inflammation. To charac-
terize this microbial dissemination, we performed nonselective,t & Microbe 16, 504–516, October 8, 2014 ª2014 The Authors 505
Cell Host & Microbe
IL-22RA1 Induces Opportunistic Pathogen Resistanceunbiased aerobic and anaerobic culturing together with 16S
rRNA sequencing to identify bacterial isolates from the systemic
organs. Interestingly in addition to C. rodentium, we identified
substantial and consistent breakthrough of Enterococcus faeca-
lis—a normal commensal of the mouse and human microbiota
(Figures 1D and 1E and Table S1). Dissemination of E. faecalis
was detectable from day 5 p.i., and at day 9 the systemic burden
of E. faecalis was comparable to that of C. rodentium among in-
fected Il22ra1/mice (Figures 1D and 1E and Table S1). Impor-
tantly, E. faecalis was not recovered from the organs of infected
WTmice (Table S1) or of infected Il22ra1/micewithout signs of
morbidity (data not shown).
We further examined the dissemination of enterococci in
Il22ra1/ mice using a noninfectious model of intestinal inflam-
mation, which involves treatment with dextran sodium sulfate
(DSS). DSS-treated Il22ra1/ mice showed significantly higher
weight loss and susceptibility compared to WT littermates (Fig-
ures S2F and S2G). Similarly to theC. rodentium infectionmodel,
we noted a high E. faecalis bacterial load in the livers and spleens
of DSS-treated Il22ra1/ mice (Figure 1F and Table S2). Our
data suggest that IL-22RA1 plays a role in controlling the sys-
temic dissemination of intestinal bacteria, particularly a potential
opportunistic E. faecalis species, during infectious and noninfec-
tious intestinal injuries.
AnOpportunisticE. faecalisSpeciesDisplays In Vivo and
Genetic Virulence Potential
To examine the process of enterococcal dissemination from the
gut of Il22ra1/ mice, we performed transmission electron
microscopy and immunogold labeling to identify bacteria at the
intestinal mucosa during C. rodentium infection. At day 9 p.i.,
enterococci were found in contact with the epithelial surface of
Il22ra1/ mice and within membrane-bound compartments of
enterocytes (Figures 2A and 2B). By contrast, C. rodentium-in-
fected WT mice showed no epithelial association or invasion of
E. faecalis (Figure 2A). This result suggests that E. faecalis can
directly invade the intestinal epithelium of Il22ra1/mice during
inflammation.
Next, we determined the systemic virulence of the E. faecalis
species recovered from Il22ra1/mice (termedmEF) in vivo, us-
ing a previously established enterococcal peritonitis model
(Bourgogne et al., 2008). Intraperitoneal administration of mEF
led to a higher mortality rate and a greater systemic inflammatory
response (characterized by elevated serum IL-6 and TNF-a
levels) compared to equivalent administration of C. rodentium
(Figures 2C and S4A). This finding led us to determine the relative
contribution of enterococci to the susceptibility of Il22ra1/
mice to C. rodentium infection by administering clinically rele-
vant doses of ampicillin intraperitoneally from day 5 p.i. Ampi-
cillin is an antibiotic commonly used for enterococcal septicemia
in humans and is active against mEF (minimum inhibitory con-
centration [MIC] = 1.6 mg/ml), but not C. rodentium (MIC >
125 mg/ml). Ampicillin-treated Il22ra1/ mice showed substan-
tially less weight loss and improved survival, associated with
decreased intestinal colonization and systemic dissemination
of E. faecalis (Figures 2D, S4B, and S4C), despite no alteration
in the colonization levels of C. rodentium (Figure S4D). This sug-
gests that dissemination of opportunistic E. faecalis can
contribute to the susceptibility of Il22ra1/ mice.506 Cell Host & Microbe 16, 504–516, October 8, 2014 ª2014 The AuThe ability of human pathogenic E. faecalis isolates to cause
infections has been shown to involve virulence genes that
enhance host colonization and adherence (Jett et al., 1994).
We sequenced and annotated the complete mEF genome by
comparative analysis with the previously sequenced E. faecalis
pathogenicity island (Shankar et al., 2002) and the genome of
E. faecalis V583, a hospital outbreak isolate (Figure S4E) (Paul-
sen et al., 2003). Interestingly, we identified multiple virulence
factors implicated in the pathogenesis of invasive enterococcal
infections (Figure S4E and Table S3). Notably, the mEF genome
includes a chromosome-encoded cytolysin operon (Figures 2E
and S4E), which encodes a membrane-targeting toxin often ex-
pressed by nosocomial E. faecalis isolates (Huycke et al., 1991).
Next, using the multilocus sequence typing (MLST) of previously
sequenced E. faecalis isolates from diverse human and animal
origins (McBride et al., 2007), we assessed the genetic related-
ness of mEF to 43 representative commensal and pathogenic
E. faecalis strains (Table S4A). This analysis revealed a close
phylogenetic relationship between mEF and several hospital-
associated strains, including E. faecalis V583 (Figure 2F). Taken
together, our results suggest that a genetically distinct E. faecalis
species in Il22ra1/ mice possesses the genetic virulence po-
tential to cause systemic infection.
IL-22RA1 Restricts Expansion of Opportunistic
E. faecalis during Intestinal Dysbiosis
Microbial dysbiosis often occurs during intestinal inflammation
and can potentially impair colonization resistance to pathogens
(Stecher and Hardt, 2011). We hypothesized that during
C. rodentium-induced dysbiosis, IL-22RA1 could prevent
dissemination of E. faecalis by restricting its intestinal over-
growth. By 16S rRNA pyrosequencing, we analyzed the micro-
biota composition of WT and Il22ra1/ mice during infection.
While the microbiota of WT and Il22ra1/ mice were similarly
diverse at baseline, C. rodentium infection resulted in a global
reduction of species richness and diversity (shown by the
Shannon index and rarefaction curves) that was significantly
exacerbated in Il22ra1/ mice (Figures 3A and S5A). Clustering
analysis further showed that the microbial community structure
of WT and Il22ra1/ mice underwent distinct shifts during
infection (Figure 3B). UnlikeWT equivalents, themicrobiota of in-
fected Il22ra1/mice was characterized by a much higher pop-
ulation of C. rodentium (54% ± 34.9% compared to 11.4% ±
7.3% in WT controls; p value < 107) and severe depletion of
the health-associated Lactobacillaceae, Bifidobacteriaceae,
and Ruminococcaceae families (Figures 3B and S5B). Notably,
all infected Il22ra1/ mice displayed a clear and consistent
overgrowth of Enterococcus spp., which was not detectable in
WT equivalents (Figure 3B).
Using group-specific qPCR and selective plating, we indepen-
dently confirmed that Il22ra1/mice were colonized by a higher
abundance of Enterobacteriaceae and Enterococcus spp., both
within the intestinal lumen and at the mucosa (Figures S5C and
S5D). Immunofluorescence labeling further revealed greater
adherence of these pathogens to the colonic crypts of infected
Il22ra1/mice (Figure 3C).Notably, bymonitoringEnterococcus
colonization over the course of C. rodentium infection, we de-
tected a remarkable (3 log-fold) increase among Il22ra1/
mice compared to WT equivalents (Figure 3D). Similarly, duringthors
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Figure 2. A Pathogenic Enterococcus faecalis Isolate Harbors Virulence Factors, Translocates Intracellularly in Il22ra1-Deficient Mice, and
Causes Lethal Septicemia
(A) Transmission electron micrographs of C. rodentium-infected WT and Il22ra1/ mice cecal tissues, showing translocation of a coccal bacterium.
(B) Enterococcus-specific immunogold labeling (arrows) of an intracellular bacterium. Scale bar, 500 nm.
(C) Survival of WT mice infected i.p. with either C. rodentium or E. faecalis (n = 10–12).
(D) Survival C. rodentium-infected WT mice and Il22ra1/ mice given i.p. ampicillin or PBS. Log-rank p value of two independent experiments (n = 5 each).
(E) Schematic alignment of the cytolysin operon and flanking genes of mEF and the E. faecalis pathogenicity island. Blue, cytolysin and aggregation substance;
black, other pathogenicity island-associated genes; triangles, transposase and IS elements. rpiR, family transcriptional regulator; PTS, phosphotransferase
system; CylI, cytolysin immunity protein; CylA, cytolysin activator; CylB, cytolysin B ABC-type transporter; CylM, cytolysin subunit modifier; CylL+S, cytolysin
subunits L–S; CylR1+R2, cytolysin regulators R1 and R2.
(F) MLST-based phylogenetic relationship between mEF and nosocomial (red), community/probiotic (green), and animal (blue) E. faecalis strains. See also
Figure S4 and Table S3.
Cell Host & Microbe
IL-22RA1 Induces Opportunistic Pathogen ResistanceDSS-induced colitis, we observed a much greater expansion of
Enterococcus spp. in the lumen and mucosa of Il22ra1/ mice
(2 log-fold relative to WT littermates) (Figure S5E).
Intestinal dysbiosis can generally enhance the growth of facul-
tative anaerobes such as theGram-negative Enterobacteriaceae
(Lupp et al., 2007; Winter et al., 2013). Therefore, among the
facultative anaerobic Enterococcus spp., we next sought to
determine the expansion dynamics of E. faecalis specifically.
By analyzing the 16S rRNA sequences of single enterococcal
colonies, we identified a predominant expansion of E. faecalis
among various enterococci in the microbiota of Il22ra1/ mice
(from 16% to 70% in the feces and 82% in the cecal mucosa)
(Figure 3E). The vast majority of other enterococcal species in
the mouse microbiota were identified as E. gallinarum, a com-
mon animal commensal rarely known to causes disease (AriasCell Hosand Murray, 2012). By contrast, no significant change in the pro-
portion of E. faecalis was detected in WT mice infected with
C. rodentium (WT versus Il22ra1/ mice: p < 0.01). Similarly,
during DSS-induced colitis, Il22ra1/ mice had a significantly
greater expansion of E. faecalis thanWT littermates (Figure S5F).
Thus, the absence of IL-22RA1 appears to allow overcoloniza-
tion by E. faecalis in relation to other Enterococcus spp. during
intestinal inflammation.
To further exclude the possibility that the expansion of
E. faecalis observed may be influenced by the presence of mul-
tiple subspecies, which cannot be detected by 16S rRNA gene
sequencing, we isolated 30 independent E. faecalis isolates
from different WT and Il22ra1/ mice colonies over time (Table
S4B). Whole-genome sequencing and in vitro hemolytic assays
indicated that the microbiota of WT and Il22ra1/ micet & Microbe 16, 504–516, October 8, 2014 ª2014 The Authors 507
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C
D E
Figure 3. IL-22RA1 Signaling Restricts Intestinal Dysbiosis and Enterococcus faecalis Overcolonization during C. rodentium Infection
(A) Shannon diversity index of the fecal microbiota of WT and Il22ra1/ mice (mean ± SEM) before C. rodentium infection (day 0) and at day 9 p.i. *p < 0.05,
**p < 0.001, ***p < 0.0001.
(B) Cluster dendogram of the microbial community structures of WT and Il22ra1/ (KO) fecal and cecal microbiota (n = 3) before infection (day 0) and at day 9 p.i.
at the operational taxonomic unit (OTU) level. Bar graphs represent proportional abundance.
(C) Immunofluorescence of C. rodentium and Enterococcus spp. in the cecum of infected WT and Il22ra1/ mice. DAPI, cell nuclei. Scale bar, 50 mm.
(D) Fecal Enterococcus shedding of WT and Il22ra1/ mice (n = 6–15) by selective plating, showing significant overgrowth during C. rodentium infection.
(E) Selective plating and 16S rRNA sequencing profile of enterococci in the feces and cecal mucosa of infected WT (n = 15) and Il22ra1/ mice (n = 40) in five
independent experiments, showing preferential expansion of E. faecalis (red) relative to other intestinal enterococci (E. gallinarum, gray). Shown are numbers of
Enterococcus sequences matched to a species ID.
See also Figure S5.
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IL-22RA1 Induces Opportunistic Pathogen Resistancecontained the same E. faecalis isolate and that this isolate was
recovered repeatedly in the feces, livers, and spleens of
Il22ra1/mice (Table S4B). Taken together, our results demon-
strate that IL-22RA1 plays a role in limiting intestinal colonization
and dissemination of a particular virulent E. faecalis isolate.
Epithelial IL-22RA1 Signaling Mediates Diverse
Antimicrobial and Glycosylation Factors
The cytokine IL-22 has been shown to enhance pathogen
defense by inducing the bactericidal lectin RegIIIg (Zheng
et al., 2008), which can inhibit various Gram-positive microbes508 Cell Host & Microbe 16, 504–516, October 8, 2014 ª2014 The Auin vitro (Cash et al., 2006), and limit colonization of vancomy-
cin-resistant Enterococcus faecium (VRE) in the small intestine
(Kinnebrew et al., 2010). During C. rodentium infection,
Il22ra1/ mice indeed showed diminished expression levels of
RegIIIg (Figure S6A). To directly determine whether RegIIIg me-
diates resistance to opportunistic E. faecalis in vivo, we infected
RegIIIg-/- mice orally with C. rodentium. RegIIIg deficiency does
not appear to influence the colonization of C. rodentium or
E. faecalis in the feces or cecal lumen (Figures 4A–4D). However,
mucosal colonization of E. faecalis at day 9 p.i. increased among
RegIIIg/ mice (Figure 4D). This is consistent with an inhibitorythors
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Figure 4. RegIIIg–/– Mice Did Not Show
Enhanced Susceptibility to C. rodentium
(A–E) WT and RegIIIg/ mice were infected
orally with 109 C. rodentium. (A) Shedding of
C. rodentium and (B) E. faecalis over the course of
infection. Bacterial load of (C) C. rodentium and
(D) E. faecalis in the cecal lumen and mucosal tis-
sues, determined by selective plating. (E) Cecal
histopathology of C. rodentium-infected WT and
RegIIIg/ mice at day 9 p.i., showing similar
submucosal edema (asterisks) and inflammatory
infiltrates (arrows). Scale bar, 100 mm. Results are
from three independent experiments (n = 6–8
each).
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IL-22RA1 Induces Opportunistic Pathogen Resistanceactivity of RegIIIg against adherence by Gram-positive microbes
(Vaishnava et al., 2011). However, all RegIIIg/ mice (n = 14)
survived the infection, showing a level of intestinal histopatholo-
gy similar to that of WT and no evidence of systemic bacterial
dissemination (Figures 4E and S6B). Thus, additional factors
downstream of IL-22RA1may be necessary for the maintenance
of intestinal colonization resistance.
To interrogate IL-22RA1 signaling specifically at the intestinal
epithelium, we derived primary colonic organoids from WT and
Il22ra1/ mice (Sato et al., 2011) and evaluated their global
transcriptomes by deep RNA sequencing. Il22ra1/ organoids
displayed a normal morphology, characterized by columnar en-
terocytes with microvilli, tight junctions, and mucus-producing
goblet cells (Figures 5A and S6C). Consistent with the epithelial
expression of IL-22RA1, in vitro stimulationwith IL-22 led to an in-
ductionof theknownantimicrobialsRegIIIb, RegIIIg, S100a8, and
S100a9 inWTand Il22/organoids, but not Il22ra1/organoidsCell Host & Microbe 16, 504–51(Figure S6D). Next, hierarchical clustering
of RNA-seq data from WT and Il22ra1/
organoids upon IL-22 stimulation de-
monstrated their distinct genome-wide
expression profiles (Figure 5B). Factors
involved in inflammatory response, anti-
microbial processes, and wound healing
were significantly upregulated, consistent
with the previously established functions
of the IL-22/IL-22RA1 pathway (Figures
5C and S6E and Tables S5A–S5C).
Conversely, genes encoding cellular
metabolic processes and DNA replication
were downregulated (Figure S6E and Ta-
ble S5D). Notably, a variety of proteases
(e.g., Prss22, Prss27, Slpi) and peroxi-
dases (e.g.,Gpx2,Duox1,Duox2,Duoxa2)
with antimicrobial activity, together with
innate recognition molecules (Tmem173,
Zbp1), were also induced by IL-22RA1
signaling, highlighting the unexpectedly
diverse antimicrobial function of this
pathway (Figure S6F).
Among genes upregulated by IL-22RA1
signaling, we further identified a range
of susceptibility genes to inflammatory
bowel disease (Sec1, Fut2, Muc1,Prdm1, Xbp1, Nupr1, Erbb3, Efemp2, Chac1, Ppbp, Cxcl5,
Stat3, Slc9a3, Bcl2l15) (Jostins et al., 2012), psoriasis (Rel,
Nos2), and rheumatoid arthritis (Stom, Ptpn22) (Eyre et al.,
2012) represented by a Stat3-focused cluster (Figure 5D).
This finding underlines the complex involvement of the IL-22/
IL-22RA1 axis in human inflammatory diseases linked to patho-
logical host-microbial interactions and supports the utility of in-
testinal organoids for dissecting the functional consequences
of IL-22RA1 signaling. Finally, we observed a high enrichment
of protein glycosylation genes induced by IL-22RA1 (p < 104;
Figures 5C and S6E and Tables S5A–S5C), which suggests a
role for epithelial glycosylation in intestinal pathogen resistance.
Fucosylated Glycan Expression Enhances Colonization
Resistance in Il22ra1–/– Mice
Glycoconjugates produced by the intestinal epithelium provide
a rich source of host-derived complex carbohydrates that can6, October 8, 2014 ª2014 The Authors 509
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Figure 5. RNA-Seq of IL-22RA1 Signaling in Colonic Epithelial Organoids Identifies Factors Associated with Host-Microbe Interactions
(A) LacZ staining ofWT and Il22ra1/ organoids (scale bar, 100 mm) (left) and transmission electronmicroscopy of an Il22ra1/ organoid withmicrovilli (Mv), tight
junctions (arrowheads), and goblet cell (G) (right; scale bar, 1 mm).
(B) RNA-seq transcriptomes of colonic organoids from wild-type (WT) and Il22ra1/ (KO) mice (n = 4) treated with IL-22 or untreated (Ctrl) in technical replicates,
showing hierarchical clustering. Colors indicate levels of correlation (low, light green-yellow; high, dark green-blue).
(C) Enriched biological processes among upregulated (orange) and downregulated (blue) genes downstream of IL-22RA1 signaling, with selected genes
associated with glycosylation.
(D) Stat3-focused interaction network of genes induced by IL-22RA1 signaling (p < 1012), 18 of which are associated with human susceptibility to chronic in-
flammatory diseases (gold). Lines indicate protein-protein interactions (dark/light blue), coexpression (black), colocalization (gray), and shared protein domains
(cyan). See also Figure S6.
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IL-22RA1 Induces Opportunistic Pathogen Resistanceimpact the microbiota structure and function (Becker and
Lowe, 2003). Among IL-22RA1-induced genes linked to epithe-
lial glycosylation, Fut2 encodes an a1,2-fucosyltransferase
highly expressed in the distal gut (Bry et al., 1996). The FUT2
enzyme is responsible for the expression of ABO histo-blood
group antigens at the intestinal mucosa (Kelly et al., 1995).
Importantly, Fut2 expression may influence the microbiota (Ka-
shyap et al., 2013) and host susceptibilities to various bacterial
pathogens (e.g., Campylobacter jejuni and Helicobacter pylori)
and autoimmune disorders (e.g., Crohn’s disease) (Ilver et al.,
1998; McGovern et al., 2010; Ruiz-Palacios et al., 2003). We
found that Fut2 is highly upregulated by IL-22RA1 signaling510 Cell Host & Microbe 16, 504–516, October 8, 2014 ª2014 The Auboth in cultured organoids (p = 2.21 3 10188) and during
C. rodentium infection in vivo (Figure 6A and Table S5). Accord-
ingly, the intestinal mucosa of C. rodentium-infected Il22ra1/
mice showed reduced staining with the fucose-binding Lotus
tetragonolobus lectin compared to WT equivalents (Figure 6B),
indicating a decreased fucosylation level in the absence of
IL-22RA1 signaling.
To test if induction of epithelial fucosylation mediated by IL-
22RA1 may contribute to intestinal host defense, we admin-
istered physiologically relevant doses of 20-fucosyllactose
(20FL), an a1,2-fucosylated oligosaccharide, orally to Il22ra1/
mice during C. rodentium infection. Treatment with 20FL fromthors
Cell Host & Microbe
IL-22RA1 Induces Opportunistic Pathogen Resistanceday 4 p.i. significantly attenuated the early morbidity and mor-
tality of infected Il22ra1/ mice (Figure 6C). Administration of
blood group H disaccharide (another a1,2-fucosylated mole-
cule similar to the mucosal antigen mediated by the FUT2
enzyme) similarly led to attenuation of the infection outcome
in Il22ra1/ mice, while administration of lactose alone did
not (Figure 6C).
We next investigated the beneficial effect of fucosylated
glycans in Il22ra1/ mice by assessing their histopathology, in-
flammatory responses, and bacterial colonization. 20FL treat-
ment did not appear to significantly reduce intestinal pathology
or the Th1/Th17 inflammation in Il22ra1/ mice at day 9 p.i.
(Figures 6D–6G). We also observed similar C. rodentium coloni-
zation between 20FL-treated and PBS controls (Figure 7A). How-
ever, luminal and mucosal colonization of E. faecalis significantly
decreased among the 20FL-treated group (Figure 7B). This corre-
lates with lower levels of E. faecalis dissemination and of sys-
temic IL-6 and TNF-a (Figures 7C and 7D), indicating that
intestinal abundance of fucosylated molecules may play a role
in the restriction of E. faecalis in the microbiota.
Within the intestinalmicrobiota, someobligate anaerobes such
as the Ruminococcaceae andBacteroides spp.may benefit from
host-derived fucosylated glycans (Marcobal et al., 2011;Martens
et al., 2008). We reasoned that fucosylated glycans in the intes-
tine could restrict colonization by opportunistic pathogens
(e.g., E. faecalis) in part by enhancing the growth of some com-
mensals. By 16S rRNA sequencing, we compared themicrobiota
diversity and composition of Il22ra1/mice treated with 20FL to
PBS-treated littermate controls during C. rodentium infection.
While no significant difference was observed in the baseline
microbiota between both groups, 20FL treatment resulted in an
increase of bacterial species richness and diversity (shown by
the Shannon diversity index) by day 9 p.i. (Figure 7E). Further-
more, analyses based on the community structure revealed a
remarkable shift in the microbial composition upon 20FL treat-
ment (weighted UniFrac; p < 0.001) (Figure 7F). In particular, we
detected a significantly greater abundance of Bacteroides spp.
(2.4-fold; p < 0.0001) and Ruminococcaceae (7.9-fold; p <
0.0001) in the 20FL-treated group. Thus, our results suggest
that IL-22RA1-mediated production of intestinal fucosylated
conjugates plays a role in colonization resistance by restoring
the anaerobic commensal diversity.
DISCUSSION
Given that IL-22 dysregulations are implicated in many human
diseases linked to pathological host-microbiota interactions (Sa-
bat et al., 2014), and Il22 deficiency can lead to different infection
susceptibility phenotypes (Feinen and Russell, 2012; Graham
et al., 2011), we reasoned that the indigenous microbiota could
be a critical factor for disease induction. Although absence of
IL-22 has been reported to associate with a colitogenic micro-
biota (Behnsen et al., 2014; Zenewicz et al., 2013), we found
that our Il22ra1/ mice harbor a microbiota highly similar (in
both diversity and community structure) to that of WT controls.
This difference underscores the potential impact of animal hus-
bandry conditions in different facilities and suggests that factors
besides a healthy SPF microbiota might be necessary for dis-
ease induction in Il22ra1/ mice.Cell HosWe observed that Il22ra1 deficiency predisposes mice to a
severe disseminated bacterial infection upon disruption of the
microbiota byC. rodentium infection or DSS colitis. Although ex-
traintestinal spread of C. rodentium has been reported in Il22/
mice (Zheng et al., 2008), the contribution of invasion by
C. rodentium or other intestinal bacteria to host susceptibility
has not been fully explored. We identified that an E. faecalis
isolate was the predominant intestinal bacterium that dis-
seminates among susceptible Il22ra1/ mice and that this
E. faecalis isolate possesses a range of important virulence
factors relevant for nosocomial disease in humans. Notably,
E. faecalis possesses a functional cytolysin associated with
bacterial invasion and virulence (Huycke et al., 1991) and is
capable of invading the intestinal epithelium in a manner similar
to that of the human pathogen E. faecalis V583 (Benjamin et al.,
2013). Furthermore, mice are highly susceptible to systemic
E. faecalis infection, and C. rodentium-infected Il22ra1/ mice
may be rescued through antibiotic inhibition of E. faecalis.
Thus, E. faecalis represents an opportunistic pathogen capable
of disease induction in the Il22ra1/ host.
Intestinal dysbiosis often acts as a predisposing factor to
infectious diseases, as diverse bacterial pathogens such as S.
Typhimurium and Clostridium difficile may exploit disruptions
of the microbiota to establish replicative niches (Lawley et al.,
2012; Stecher et al., 2007). Here we found that while WT mice
were able to maintain a low level of colonization by E. faecalis
(104–105 colony-forming units [cfu]/g of feces), Il22ra1/
mice were predisposed to unrestricted E. faecalis proliferation
(107–109 cfu/g) during bothC. rodentium- andDSS-induced dys-
biosis. Moreover, we noted a preferential expansion of a patho-
genic E. faecalis variant in comparison to other commensal
enterococci (i.e., E. gallinarum). Thus, although intestinal inflam-
mation is thought to generally promote the growth of facultative
anaerobes, our result highlights the importance of assessing in-
testinal dysbiosis at the species level to potentially distinguish
between disease-causing and commensal microbes belonging
to the same bacterial taxa.
The antimicrobial response of IL-22 to bacterial pathogens has
been shown to involve RegIIIg, which is highly expressed in the
small intestine and bactericidal against Gram-positive bacteria
(Cash et al., 2006; Kinnebrew et al., 2010). Interestingly, while
we found that RegIIIg/ mice had increased levels of mucosa-
associated E. faecalis, their expansion in the luminal microbiota
and translocation to systemic organs were unaffected. Thus,
together with the diverse network of antimicrobial factors uncov-
ered by our RNA-seq analysis of epithelial organoids, this finding
underlines themultifactorial nature of IL-22RA1 signaling in host-
microbiota interactions.
By our organoid transcriptomic approach, we further identified
the a1,2-fucosyltransferase gene Fut2 as a candidate factor
regulated by IL-22RA1 signaling. Fut2 is critically involved in
regulating the fucose nutrient environment of themicrobiota (Ka-
shyap et al., 2013) as well as host susceptibility to bacterial and
viral pathogens (Ilver et al., 1998; Lindesmith et al., 2003; Ruiz-
Palacios et al., 2003). Interestingly, fucosylated glycans typically
increase during gut maturation (Bry et al., 1996) and infection
(Deatherage Kaiser et al., 2013), a process that is thought to
beneficially enhance bacterial colonization. Here we found that
epithelial expression of Fut2 is directly induced by IL-22RA1t & Microbe 16, 504–516, October 8, 2014 ª2014 The Authors 511
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Figure 6. IL-22RA1-Mediated Fucosylated Glycan Expression Contributes to Host Defense
(A) Cecal Fut2 transcripts of WT and Il22ra1/ mice (n = 9–12) at day 9 p.i. with C. rodentium.
(B) Immunofluorescence staining of WT and Il22ra1/ cecal tissues with Lotus tetragonolobus lectin (green).
(legend continued on next page)
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Figure 7. Fucosylated Glycan Expression Enhances Colonization Resistance to E. faecalis
(A–D) C. rodentium-infected WT mice and groups of Il22ra1/ littermates were treated orally with 20-fucosyllactose (20FL) or PBS. Shown are (A) C. rodentium
shedding, (B) E. faecalis cfus in the colonic lumen andmucosa (gray area, detection limit), (C) E. faecalis cfus in the liver and spleen, and (D) serum IL-6 and TNF-a
levels at day 9 p.i. Mean ± SEM of data from three independent experiments (n = 3–5 each); *p < 0.05, **p < 0.01, ***p < 0.0001.
(E) Shannon diversity index of the fecal microbiota before infection (day 0) and at day 9 p.i.
(F) Cluster dendogram of the fecal microbiota community structures of 20FL-treated Il22ra1/ mice and PBS-treated controls (Ctrl). Bar graphs represent
proportional abundance.
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IL-22RA1 Induces Opportunistic Pathogen Resistancesignaling, which is consistent with a lower level of fucosylated
glycans at the colonic mucosa of Il22ra1/ mice during
infection.
We further observed that restoration of fucosylated mole-
cules in the intestine can attenuate the susceptibility of
Il22ra1/ mice and decrease E. faecalis colonization at the
intestinal lumen and mucosa. Although 20FL administration(C–E) WT mice and groups of Il22ra1/ littermates were treated orally with 20-fuc
PBS between days 5 and 8 p.i. during C. rodentium infection. Shown are (C) surv
total number of cLP leukocytes at day 9 p.i.
(F and G) qPCR of (F) Th1 cytokines (IFNg, TNF-a, IL-1b, IL-6) and (G) Th17-asso
Cell Hosdid not appear to have an anti-inflammatory effect, we de-
tected a clear impact on the microbiota diversity and compo-
sition, characterized by an increased abundance of some
anaerobic commensal populations. Interestingly, colonization
resistance to VRE has been shown to involve Barnesiella
spp., which are Gram-negative saccharolytic commensals
belonging to the family Porphyromonadaceae (Ubeda et al.,osyllactose (20FL), blood group H disaccharide (or H antigen; H-Ag), lactose, or
ival (left) and weight loss (right), (D) histopathology (scale bar, 200 mm), and (E)
ciated cytokines (IL-17a, IL-17f, IL-21, IL-22) in the cecal tissues at day 9 p.i.
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IL-22RA1 Induces Opportunistic Pathogen Resistance2013). In agreement with this study, we observed a higher
colonization of Porphyromonadaceae in the 20FL-treated
group (1.5-fold). Moreover, the fucose-utilizing, anaerobic
Ruminococcaceae and Bacteroides spp. were remarkably en-
riched (7.9-fold and 2.4-fold, respectively), which further sup-
ports the notion that intestinal fucosylation provides a nutrient
foundation for symbiotic commensals (Hooper and Gordon,
2001).
The intestinal microbiota represents a complex and highly
controlled nutrient network that is crucial for colonization re-
sistance to diverse bacterial pathogens. For example, upon
depletion of commensal microbes, S. Typhimurium can upre-
gulate its fucose utilization operon (Deatherage Kaiser et al.,
2013) and exploit the increased abundance of fucose and
sialic acids to colonize the intestine (Ng et al., 2013). Thera-
peutic modulation of the microbiota, by dietary intake of
prebiotic substances or administration of health-associated
bacteria, therefore provides an attractive opportunity for the
management of intestinal infections (Lawley et al., 2012).
Here, our data support a mechanistic model whereby the IL-
22RA1/Fut2 axis is involved in the maintenance of a diverse
healthy microbiota, which in turn promotes intestinal coloniza-
tion against the opportunistic pathogen E. faecalis. Further
insights into the molecular interactions between IL-22RA1-
mediated glycosylation pathways and symbiotic members of
the intestinal microbiota could potentially yield opportunities
for the treatment of intestinal dysbiosis in infectious and auto-
immune diseases.
EXPERIMENTAL PROCEDURES
Mouse Infection
Il22ra1tm1a/tm1a, RegIIIgtm1a/tm1a, and WT C57BL/6N mice were maintained
and phenotyped by the Sanger Mouse Genetics Programme (White et al.,
2013). Endogenous Il22ra1 expression was detected by overnight incubation
with 0.1% (w/v) X-gal (Invitrogen). All animals were kept under specific path-
ogen-free conditions, and colony sentinels tested negative for Helicobacter
spp. Mice were infected orally with 109 cfu of Kanamycin (Kan)- and nalidixic
acid (Nal)-resistant luminescent Citrobacter rodentium ICC180 (Wiles et al.,
2006) or intravenously (i.v.) with 105 cfu Salmonella enterica serovar Typhimu-
rium M525 TETc (Clare et al., 2003). Where indicated, C. rodentium-infected
mice were administered intraperitoneal (i.p.) ampicillin (50 mg/kg; Sigma-Al-
drich), oral 20-fucosyllactose, H disaccharide, lactose (2 mg/day; Carbo-
synth), or PBS controls. DSS colitis was induced by administering 2% (w/v)
DSS (MP Biomedicals) in drinking water for 7 days, followed by normal auto-
claved water. The care and use of mice were in accordance with the UK
Home Office regulations (UK Animals Scientific Procedures Act 1986) and
were approved by the Sanger Institute’s Animal Welfare and Ethical Review
Body.
C. rodentium Immunoglobulin ELISA
NUNC Maxisorp ELISA plates were coated overnight with 100 mg/well Citro-
bacter EspA protein and blocked with 3% BSA (Sigma-Aldrich). Serum and
fecal supernatant samples were added in 1:5 serial dilutions for 1 hr at 37C.
We detected immunoglobulin levels with HRP-conjugated rabbit a-mouse to-
tal IgG or IgA antibodies (1/1,000; Invitrogen).
Quantitative Real-Time PCR
Total RNA was extracted from mouse cecal tissues using the RNeasy Mini Kit
(QIAGEN). Quantitative real-time PCRwas conductedwith a 7900HTRealTime
PCR system (Applied Biosystems), using ABsolute Blue Rox Mix (Thermo Sci-
entific), TaqMan primers, and probes as detailed in the Supplemental Experi-
mental Procedures.514 Cell Host & Microbe 16, 504–516, October 8, 2014 ª2014 The Au16S rRNA-Based Identification of Bacterial Species
To identify microbial species from the livers and spleens of mice, we homog-
enized mouse tissues aseptically under laminar flow. Organ lysates were
immediately cultured in nonselective Luria-Bertani (LB), BHI (Brain Heart
Infusion), and FAA (Fastidious Anaerobe Agar) media under aerobic and anaer-
obic conditions for 36–48 hr. All colonies from each plate, or within a defined
section, were picked in an unbiased manner for DNA extraction and 16S
rRNA gene sequencing using the universal primers: 7F, 50-AGAGTTTGA
TYMTGGCTCAG-30; 926R, 50-ACTCCTACGGGAGGCAGCAG-30. Bacterial
identifications were performed using the 16S rRNA NCBI Database for Bacte-
ria and Archeae.
Bacterial Genomic and Phylogenetic Analysis
Genomic DNA from Enterococcus faecalis isolates were prepared from
overnight cultures using a standard phenol-chloroform extraction proce-
dure and sequenced by Illumina MiSeq 2000. We performed genome as-
sembly and comparative genomics with the previously sequenced
E. faecalis V583 genome (Paulsen et al., 2003) and the E. faecalis
MMH594 pathogenicity island (GenBank accession number AF454824)
(Shankar et al., 2002). To profile the diversity of enterococci in the mouse
microbiota, we sequenced the 16S rRNA gene of single enterococcal col-
onies on selective Bile Esculin Azide agar (Sigma-Aldrich) in an unbiased
manner. Representative Enterococcus faecalis isolates were selected for
whole-genome sequencing, generating 503 genome coverage/isolate.
Phylogenetic analysis was performed using the previously published full
and draft genomes of 43 E. faecalis strains collected from diverse human
and animal sources (McBride et al., 2007). See also Supplemental Experi-
mental Procedures.
Microbiota Analyses
Bacterial DNA was obtained using the FastDNA Spin Kit for Soil (MBio)
and FastPrep Instrument (MPBiomedicals). V5-V3 regions of bacterial 16S
rRNA genes were PCR amplified with high-fidelity AccuPrime Taq Polymerase
(Invitrogen) and primers: 338F, 50-CCGTCAATTCMTTTRAGT-30; 926R, 50-
ACTCCTACGGGAGGCAGCAG-30. Libraries were sequenced by 454 (Roche)
or MiSeq (Illumina). Analyses were performed with the mothur software
(Schloss et al., 2009), using quality filtering and analysis parameters as
described in the Supplemental Experimental Procedures. For quantification
of group-specific bacteria, we used the following primers: F, 50-ATGGC
TGTCGTCAGCTCGT-30; R, 50-CCTACTTCTTTTGCAACCCACTC-30 (for En-
terobacteriaceae) and F, 50-CCCTTATTGTTAGTTGCCATCATT-30; R, 50-
ACTCGTTGTACTTCCCATTGT-30 (for Enterococcus spp.).
Intestinal Organoid Transcriptomics
Organoids frommouse colons were isolated and cultured in vitro as described
(Sato et al., 2011). For RNA-seq, 1-week-old organoids of WT and Il22ra1/
mice (n = 4) were treated with IL-22 (50 ng/ml) or controls in complete growth
medium.mRNA libraries were prepared using the Illumina TruSeq protocol and
sequenced by Illumina HiSeq to yield 6.4 ± 0.25 giga-base pairs (Gbp)/sam-
ple. Normalized read counts (aligned to the reference mm10/NCBIM37
genome) were used to assess the statistical significance of the interaction be-
tween IL-22 treatment and Il22ra1 genotype, as described in the Supplemental
Experimental Procedures. At p < 1012, 364 genes were identified as upregu-
lated and 197 genes were identified as downregulated by IL-22/IL-22RA1
signaling.
Statistical Analysis
We applied nonparametric Mann-Whitney U tests for pairwise statistical com-
parisons and two-way ANOVA for comparisons of grouped data using the
Prism 5.0 software (GraphPad).
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